Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-25-067841
Filing Date
2025-07-15
Accepted
2025-07-14 20:22:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2520539d1_s1.htm S-1 318196
2 EXHIBIT 5.1 tm2520539d1_ex5-1.htm EX-5.1 8882
3 EXHIBIT 23.1 tm2520539d1_ex23-1.htm EX-23.1 2612
4 EX-FILING FEES tm2520539d1_ex-filingfees.htm EX-FILING FEES 9893
5 GRAPHIC tm2520539d1_ex5-1img001.jpg GRAPHIC 2705
  Complete submission text file 0001104659-25-067841.txt   344567
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288667 | Film No.: 251122896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)